|
|
||||||||
Departments of Nuclear Medicine, Pathology, Radiology and Oncology, Rambam Medical Center
B. Rappaport Faculty of Medicine, TechnionIsrael Institute of Technology, Haifa, Israel
Correspondence: For correspondence and reprints contact: Dov Front, MD, PhD, Department of Nuclear Medicine, Rambam Medical Center, Haifa 35254, Israel.
ABSTRACT
Gallium-67 is now widely used in the management of lymphoma patients. It is not, however, tumor-specific and reasons for up take in nonmalignant and premalignant lesions associated with lymphoma should be recognized.Gallium-67 uptake in a mass of progressively transformed germinal centers and sarcoid-like reaction, mimicking recurrence in a 31-yr-old man with nodular lymphocytic predominance Hodgkin's disease, is described. Gallium-67 was taken up on two occasions and a recurrence was suspected. On the first occasion, abnormal uptake was present in axillary lymphnodes and on the second in mediastinal and parahilar lymphnodes. Histology of the lesions on both occasions showed progressively transformed germinal centers and sarcoid-like reaction but no evidence of Hodgkin's disease (HD). Bilateral parahilar abnormal uptake of 67Ga disappeared spontaneously without treatment after several months. The mass on CT regressed but did not disappear. This case demonstrates that the appearance of a new mass which takes up 67Ga in lymphocytic-predominance HD during a continuous clinical remission does not necessarily indicate recurrence and the need for treatment. It suggests that a biopsy should be performed to determine the nature of the lesion.
Key Words: gallium-67 scintigraphy lymphoma
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |